User contributions
From 2009.igem.org
(Latest | Earliest) View (newer 500 | older 500) (20 | 50 | 100 | 250 | 500)
- 02:00, 22 October 2009 (diff | hist) N File:Headerhome2.png (top)
- 01:58, 22 October 2009 (diff | hist) Template:Supbiotechcss1.css
- 01:56, 22 October 2009 (diff | hist) Template:Supbiotechcss1.css
- 01:55, 22 October 2009 (diff | hist) N File:Headerhome.png (top)
- 01:50, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management (→Project Management)
- 01:49, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet (→Gestion de Projet) (top)
- 01:48, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet (→Gestion de Projet)
- 01:48, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet (→Gestion de Projet)
- 01:47, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet (→Gestion de Projet)
- 01:45, 22 October 2009 (diff | hist) N File:GanttR&D.png (top)
- 01:45, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet (→Gestion de Projet)
- 01:34, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 01:33, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 01:32, 22 October 2009 (diff | hist) N Template:Supbiotechcss13.css (New page: <html> <head> <style type="text/css"> /*_______________________________________________Global______________________________________________*/ - →fond en absence de fond: body { backgroun...) (top)
- 01:31, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (top)
- 01:29, 22 October 2009 (diff | hist) N File:Headermodel.png (top)
- 01:20, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Acknowledgement (→Our Sponsors)
- 01:19, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Acknowledgement (→Our Sponsors)
- 01:18, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Remerciement (→Nos Sponsors)
- 01:16, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Remerciement (→Nos Sponsors)
- 01:15, 22 October 2009 (diff | hist) N File:Logo AirCanada.jpg (top)
- 01:12, 22 October 2009 (diff | hist) Template:SupbiotechparisFr2 (top)
- 01:10, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Team (→Team)
- 01:09, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 01:09, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 01:08, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 01:08, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 01:02, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biologie Synthetique (→Découvrez les vidéos du débat !)
- 01:01, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→The debate program)
- 01:00, 22 October 2009 (diff | hist) N File:Programme du debat ethique-iGEM SupBiotech Paris francais.pdf (top)
- 00:57, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8]) (top)
- 00:56, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→L’encapsidation du plasmide thérapeutique [2,3,4,5,6,7])
- 00:53, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector deliverance in the target organ [1,2,8]) (top)
- 00:52, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The encapsidation of the therapeutic plasmid [2,3,4,5,6,7])
- 00:51, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:49, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:48, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:47, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:47, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:46, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:45, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:44, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:43, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:43, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:42, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:41, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:38, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:37, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:35, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:33, 22 October 2009 (diff | hist) Team:SupBiotech-Paris
- 00:33, 22 October 2009 (diff | hist) N File:500px-mozilla firefox.png (top)
- 00:27, 22 October 2009 (diff | hist) Template:SupbiotechparisEn2 (top)
- 00:25, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Step Five: The cell vector internalization)
- 00:25, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Step Five: The cell vector internalization)
- 00:20, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic
- 00:18, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic
- 00:12, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Simultaneous evolution of DVS and tumor)
- 00:11, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Dispersal area of phage)
- 00:08, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Simultaneous evolution of DVS and tumor)
- 00:07, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Simultaneous evolution of DVS and tumor)
- 00:06, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Discover videos of the debate !)
- 00:04, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Discover videos of the debate !)
- 00:01, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→Discover videos of the debate !)
- 23:57, 21 October 2009 (diff | hist) Template:SupbiotechparisEn (top)
- 23:56, 21 October 2009 (diff | hist) Template:SupbiotechparisFr (top)
- 23:54, 21 October 2009 (diff | hist) Template:SupbiotechparisFr
- 23:50, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→The debate program)
- 23:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→The debate program)
- 23:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→The debate program)
- 23:48, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic (→The debate program)
- 23:48, 21 October 2009 (diff | hist) N File:Programme of ethic debate1.pdf
- 23:46, 21 October 2009 (diff | hist) N File:Miniature conférence ethique en.png (top)
- 23:40, 21 October 2009 (diff | hist) Template:SupbiotechparisEn2
- 23:39, 21 October 2009 (diff | hist) Template:SupbiotechparisEn
- 23:37, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Simulation de traitement)
- 23:32, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→DVS Efficiency)
- 23:24, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→Delivery system of the cell vector) (top)
- 23:22, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1Fr (→Système de délivrance du vecteur cellulaire)
- 23:21, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1Fr (→Système de délivrance du vecteur cellulaire)
- 23:21, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1Fr (→Système de délivrance du vecteur cellulaire)
- 23:20, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3Fr (→En résumé…) (top)
- 23:18, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Acknowledgement (→iGEM Team 2009)
- 23:17, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Lambda Phage)
- 23:16, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Lambda Phage)
- 23:16, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Safety in DVS project)
- 23:13, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→To summarize…)
- 23:12, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→Delivery system of the cell vector)
- 23:12, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→Delivery system of the cell vector)
- 23:07, 21 October 2009 (diff | hist) Template:SupbiotechparisEn
- 23:04, 21 October 2009 (diff | hist) Template:SupbiotechparisEn
- 23:03, 21 October 2009 (diff | hist) Template:SupbiotechparisFr
- 23:02, 21 October 2009 (diff | hist) Team:SupBiotech-Paris
- 23:01, 21 October 2009 (diff | hist) Team:SupBiotech-Paris
- 22:56, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography (→Title)
- 22:55, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie (→Sûreté)
- 22:54, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie (→Titre)
- 22:54, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie (→Safety)
- 22:52, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Simulation de traitement)
- 22:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Conclusion [3,4,5,6,7,8,9])
- 22:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Results [1,2])
- 22:47, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Results [1,2])
- 22:46, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Results [1,2])
- 22:46, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→The running of the study)
- 22:46, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→The running of the study)
- 22:45, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Apoptosis detection)
- 22:44, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→TP53 gene incorporation)
- 22:44, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Cancer cell line and reported gene)
- 22:43, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Context)
- 22:42, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Conclusion [3,4,5,6,7,8,9])
- 22:42, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Context)
- 22:40, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Application)
- 22:36, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→Delivery system of the cell vector)
- 22:34, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy [1])
- 22:32, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Fourth step : The cell vector dispersion)
- 22:32, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Third step : Release of the cell vector)
- 22:31, 21 October 2009 (diff | hist) N File:RépartitionvitesseparaboliqueEN.png (top)
- 22:30, 21 October 2009 (diff | hist) N File:RepèremouvementmécaniqueEn.png (top)
- 22:28, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 22:19, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 22:18, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling
- 22:17, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Treatement modeling (→Second step : Development of the tissue vector)
- 22:12, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Simulation de traitement)
- 22:08, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Cinquième étape : L’internalisation du vecteur cellulaire)
- 22:07, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Cinquième étape : L’internalisation du vecteur cellulaire)
- 22:05, 21 October 2009 (diff | hist) Team:SupBiotech-Paris
- 22:04, 21 October 2009 (diff | hist) Team:SupBiotech-Paris
- 22:04, 21 October 2009 (diff | hist) Team:SupBiotech-Paris
- 22:02, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 22:01, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Troisième étape : La libération du vecteur cellulaire)
- 22:00, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→La diffusion à travers les parois des vaisseaux sanguins)
- 21:48, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Team
- 21:47, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 21:42, 21 October 2009 (diff | hist) Template:Supbiotechcss7.css (top)
- 21:41, 21 October 2009 (diff | hist) N File:Equipehautfond.jpg (top)
- 21:35, 21 October 2009 (diff | hist) Template:Supbiotechcss7.css
- 20:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Simulation de traitement)
- 20:47, 21 October 2009 (diff | hist) N File:SimulationSBP.swf (top)
- 12:26, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Contexte)
- 02:30, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety
- 02:28, 21 October 2009 (diff | hist) N File:PrincipedeprécautionEn.jpg (top)
- 02:28, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Bioterror)
- 02:27, 21 October 2009 (diff | hist) N File:Spectrederisquedebio-terreurEn.png (top)
- 02:27, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Bioterror)
- 02:27, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Bioterror)
- 02:26, 21 October 2009 (diff | hist) N File:CaptureécranEn.png (top)
- 02:26, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Judging form)
- 02:25, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Judging form)
- 02:24, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Judging form)
- 02:22, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Judging form)
- 02:20, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Bioterror)
- 02:20, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Conclusion)
- 02:18, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Mycobacterium avium subtype avium)
- 02:18, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety (→Conclusion)
- 02:17, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Safety
- 02:03, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Discussion)
- 01:53, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Discussion)
- 01:53, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Transfection des cellules eucaryotes par le phage lambda recombiné avec la base de penton fusionnée à la protéine D (Stefania Piersanti et al., 2004))
- 01:52, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Design de la protéine de fusion)
- 01:52, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Démarche expérimentale)
- 01:52, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Objectif)
- 01:52, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Contexte)
- 01:51, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Conclusions)
- 01:51, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Plasmide antitumoral)
- 01:51, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Ciblage cellulaire)
- 01:50, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Discussion)
- 01:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Transfection des cellules eucaryotes par le phage lambda recombiné avec la base de penton fusionnée à la protéine D (Stefania Piersanti et al., 2004))
- 01:49, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Design de la protéine de fusion)
- 01:48, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Design de la protéine de fusion)
- 01:28, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Conclusion)
- 01:15, 21 October 2009 (diff | hist) File:DVS2.png (uploaded a new version of "Image:DVS2.png") (top)
- 00:54, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Résultats)
- 00:40, 21 October 2009 (diff | hist) N File:Echancyto12En.png (top)
- 00:39, 21 October 2009 (diff | hist) N File:Echancyto1En.png (top)
- 00:39, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Résultats)
- 00:35, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Conclusion)
- 00:35, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 00:32, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Discussion)
- 00:31, 21 October 2009 (diff | hist) N File:3modelmurinEn.png
- 00:31, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting (→Experimental method)
- 00:30, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Tissue targeting
- 00:28, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Biologie Synthetique
- 00:27, 21 October 2009 (diff | hist) N Template:SupbiotechparisFr2 (New page: <html> <head> <div id="drapeau" style="float: right; margin-right: -100px ;margin-top: -39px;"> <a href="https://2009.igem.org/Team:SupBiotech-Paris/HomeEn#drapeau" target="_self"> <img tit...)
- 00:26, 21 October 2009 (diff | hist) Template:SupbiotechparisEn2
- 00:26, 21 October 2009 (diff | hist) Template:SupbiotechparisEn2
- 00:24, 21 October 2009 (diff | hist) N Template:SupbiotechparisEn2 (New page: <html> <head> <div id="drapeau" style="float: right; margin-right: -100px ;margin-top: -39px;"> <a href="https://2009.igem.org/Team:SupBiotech-Paris/HomeEn#drapeau" target="_self"> <img tit...)
- 00:23, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Ethic
- 00:22, 21 October 2009 (diff | hist) Template:Supbiotechcss14.css (top)
- 00:21, 21 October 2009 (diff | hist) N File:Headerethic.png (top)
- 00:21, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→The Double Vector System) (top)
- 00:21, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System) (top)
- 00:19, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 23:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie
- 23:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography
- 23:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography (→Title)
- 23:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography
- 23:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie (→titre)
- 23:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie
- 23:05, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Mise en application du plasmide thérapeutique sur le cancer du poumon)
- 23:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Lignée cancéreuse et gène apporté)
- 23:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Incorporation du gène TP53)
- 23:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Détection de l’apoptose)
- 23:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Déroulement de l’étude)
- 23:01, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Incorporation du gène TP53)
- 23:01, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Contexte)
- 23:01, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Contexte)
- 23:00, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies géniques (→La thérapie génique [1]) (top)
- 22:54, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Plasmide Thérapeutique)
- 22:51, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Conclusion)
- 22:50, 20 October 2009 (diff | hist) N File:Principe de précaution.jpg (top)
- 22:49, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→Vectorization problems [13,14,15,16,17,18,19])
- 22:48, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 22:48, 20 October 2009 (diff | hist) N File:Spectrederisquedebio-terreur.png (top)
- 22:47, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 22:47, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 22:47, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 22:46, 20 October 2009 (diff | hist) N File:Captureécran.png (top)
- 22:44, 20 October 2009 (diff | hist) N File:RépartitionvitesseparaboliqueFR.png (top)
- 22:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 22:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 22:43, 20 October 2009 (diff | hist) N File:Repèremouvementmécaniquefr.png (top)
- 22:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 22:42, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 22:40, 20 October 2009 (diff | hist) File:Équipe2.png (uploaded a new version of "Image:Équipe2.png") (top)
- 22:37, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Déroulement de l’étude)
- 22:33, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:29, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:23, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:21, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:17, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Cellulaire (→Résultats)
- 22:12, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 22:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→The Double Vector System)
- 22:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→The Double Vector System)
- 22:11, 20 October 2009 (diff | hist) N File:DVS3En.png (top)
- 22:10, 20 October 2009 (diff | hist) N File:DVS2En.png (top)
- 22:09, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→The Double Vector System)
- 22:03, 20 October 2009 (diff | hist) File:Avecdoxy.swf (uploaded a new version of "Image:Avecdoxy.swf") (top)
- 21:59, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1Fr (→Mécanisme de détournement du système immunitaire)
- 21:58, 20 October 2009 (diff | hist) File:AMPC.png (uploaded a new version of "Image:AMPC.png") (top)
- 21:57, 20 October 2009 (diff | hist) File:DVS2.png (uploaded a new version of "Image:DVS2.png")
- 21:57, 20 October 2009 (diff | hist) File:DVS3.png (uploaded a new version of "Image:DVS3.png") (top)
- 21:50, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:49, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:49, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:48, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:47, 20 October 2009 (diff | hist) N File:DVS3.png
- 21:46, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:45, 20 October 2009 (diff | hist) File:DVS2.png (uploaded a new version of "Image:DVS2.png")
- 21:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:42, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 21:37, 20 October 2009 (diff | hist) File:Avecdoxy.swf (uploaded a new version of "Image:Avecdoxy.swf")
- 21:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Acknowledgement (→Students)
- 21:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Team (→Team)
- 21:26, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Remerciement (→Les étudiants)
- 21:26, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Remerciement (→Les étudiants)
- 21:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Remerciement (→Les étudiants)
- 21:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 21:24, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 21:22, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 21:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 21:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography
- 21:00, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Equipe (→L’équipe)
- 20:58, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Contexte)
- 20:47, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Discussion)
- 20:46, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie
- 20:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Discussion)
- 20:39, 20 October 2009 (diff | hist) N File:Echancyto12.png (top)
- 20:39, 20 October 2009 (diff | hist) N File:Echancyto1.png (top)
- 20:38, 20 October 2009 (diff | hist) N File:Temoincyto.png (top)
- 20:36, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 20:36, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 20:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 20:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 20:34, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 20:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Discussion)
- 20:26, 20 October 2009 (diff | hist) N File:Graphpoumon.png (top)
- 20:25, 20 October 2009 (diff | hist) N File:3modelmurin.png (top)
- 20:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Résultats)
- 20:17, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 20:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 20:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 20:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 20:08, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Détails du protocole expérimental)
- 20:07, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Discussion)
- 20:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 20:05, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Conclusion)
- 20:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Détails du protocole expérimental)
- 20:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Détails du protocole expérimental)
- 20:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire (→Détails du protocole expérimental)
- 20:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Ciblage Tissulaire
- 19:32, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2
- 19:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→The tissue vector: Mycobacterium avium [1,2])
- 19:29, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→The tissue vector: Mycobacterium avium [1,2])
- 19:28, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy [1])
- 19:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Acknowledgement (→Students)
- 19:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gallery
- 19:17, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography
- 19:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 19:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 19:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 19:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 19:14, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector deliverance in the target organ [1,2,8])
- 19:13, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 19:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→The Double Vector System)
- 19:10, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→The Double Vector System)
- 19:09, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 19:09, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 19:09, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 19:07, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:07, 20 October 2009 (diff | hist) N File:Bibou4.png (top)
- 19:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:05, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:05, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 19:01, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 18:59, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 18:58, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 18:58, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 18:57, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Le Double Vector System)
- 18:57, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Les problématiques de la vectorisation [13,14,15,16,17,18,19])
- 18:57, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Les problématiques de la vectorisation [13,14,15,16,17,18,19])
- 18:56, 20 October 2009 (diff | hist) N File:Bibou2.png (top)
- 18:54, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Evolution en simultanée du DVS et d'une tumeur)
- 18:53, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Evolution en simultanée du DVS et d'une tumeur)
- 18:53, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Evolution en simultanée du DVS et d'une tumeur)
- 18:52, 20 October 2009 (diff | hist) N File:Bibou3.png (top)
- 18:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/BiobricksFr
- 18:34, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/BiobricksFr
- 18:33, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector deliverance in the target organ [1,2,8])
- 18:28, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector deliverance in the target organ [1,2,8])
- 18:26, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 18:26, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector deliverance in the target organ [1,2,8])
- 18:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 18:24, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 18:22, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 18:22, 20 October 2009 (diff | hist) N File:Avecdoxy.swf
- 18:21, 20 October 2009 (diff | hist) N File:Nodoxy.swf (top)
- 17:57, 20 October 2009 (diff | hist) File:Ghjg-1-.jpg (uploaded a new version of "Image:Ghjg-1-.jpg") (top)
- 17:55, 20 October 2009 (diff | hist) File:Ghjg-1-.jpg (uploaded a new version of "Image:Ghjg-1-.jpg")
- 17:46, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→Vectorization problems)
- 17:45, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→Vector types)
- 17:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→Vector components)
- 17:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→Pharmacokinetic modification, pharmacodynamic and bioavability)
- 17:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept (→Vectorization principle)
- 17:42, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Les problématiques de la vectorisation)
- 17:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie
- 17:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography
- 17:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Les types de vecteurs)
- 17:12, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Modification de la pharmacocinétique, de la pharmacodynamique et de la biodisponibilité)
- 17:09, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Les composants d’un vecteur [3])
- 17:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Les composants d’un vecteur)
- 17:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Principe de vectorisation [1])
- 17:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Introduction1Fr (→Principe de vectorisation)
- 16:57, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Acknowledgement (→UMR CNRS 8121 from Gustave Roussy Institute)
- 16:56, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Remerciement (→UMR CNRS 8121 de l'Institut Gustave Roussy)
- 16:48, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Cinquième étape : L’internalisation du vecteur cellulaire)
- 16:47, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Cinquième étape : L’internalisation du vecteur cellulaire)
- 16:46, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 16:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 16:42, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 16:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 16:39, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Quatrième étape : La dispersion du vecteur cellulaire)
- 16:38, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Troisième étape : La libération du vecteur cellulaire)
- 16:37, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Troisième étape : La libération du vecteur cellulaire)
- 16:36, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Troisième étape : La libération du vecteur cellulaire)
- 16:36, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Troisième étape : La libération du vecteur cellulaire)
- 16:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Troisième étape : La libération du vecteur cellulaire)
- 16:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Deuxième étape : Le développement du vecteur tissulaire)
- 16:34, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Deuxième étape : Le développement du vecteur tissulaire)
- 16:12, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Conclusion1
- 16:09, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3
- 16:08, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2
- 16:07, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1
- 16:04, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Team (→Team)
- 16:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept
- 16:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Team
- 16:00, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Team (→Team)
- 15:59, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Team (→Team)
- 15:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 15:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet
- 15:24, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gestion de projet (→Gestion de Projet)
- 15:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Première étape : le développement de la tumeur en fonction du temps)
- 15:14, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Conclusion1 (→Conclusion)
- 15:14, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Conclusion1 (→Conclusion)
- 15:14, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Conclusion1
- 15:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Segmentation du modèle)
- 15:11, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Segmentation du modèle)
- 15:08, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→Immune system resistance mechanism)
- 15:07, 20 October 2009 (diff | hist) File:AMPC.png (uploaded a new version of "Image:AMPC.png")
- 15:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2
- 14:59, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1
- 14:58, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→To sum up…)
- 14:56, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→The tissue vector: Mycobacterium avium [1,2])
- 14:54, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept
- 14:54, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1
- 14:48, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Conclusion)
- 14:46, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy and challenges [1,3])
- 14:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Conclusion)
- 14:44, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy [1])
- 14:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Administration mode [2])
- 14:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy)
- 14:42, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy and challenges)
- 14:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies (→Gene therapy and challenges)
- 14:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Gene therapies
- 14:26, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies (→Conclusion)
- 14:26, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies (→The genetic pharmacology interest [1,2])
- 14:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies (→The genetic pharmacology interest [1,2])
- 14:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies (→The Genetic Pharmacology interest)
- 14:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies (→Actual medicines [1])
- 14:24, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies (→Actual medicines)
- 14:23, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Current therapies
- 14:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Conclusion1Fr
- 14:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 14:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→BioBricks)
- 14:10, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Sûreté en laboratoire)
- 14:08, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Introduction)
- 14:07, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Introduction)
- 14:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 14:06, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Formulaire pour les juges)
- 14:04, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Les tests en environnement ouvert)
- 14:04, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Libération accidentelle)
- 14:04, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Libération accidentelle)
- 14:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 14:03, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→La bio-terreur)
- 14:02, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Conclusion)
- 14:00, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→BioBricks)
- 13:59, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→BioBricks)
- 13:57, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→BioBricks)
- 13:56, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→BioBricks)
- 13:56, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Plasmide Thérapeutique)
- 13:54, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Phage Lambda)
- 13:53, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:49, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Sûreté (→Mycobacterium avium sous type avium)
- 13:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Evolution en simultanée du DVS et d'une tumeur)
- 13:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Cinquième étape : L’internalisation du vecteur cellulaire)
- 13:35, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Modeling du traitement (→Evolution en simultanée du DVS et d'une tumeur)
- 13:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/BiobricksFr
- 13:29, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:28, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/BiobricksFr
- 13:28, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/BiobricksFr
- 13:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:24, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:21, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:21, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 13:14, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 12:52, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:52, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:51, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:50, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:46, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:45, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:43, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:41, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible [1,2,8])
- 12:36, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1 (→Cell wall and tissue vector envelope)
- 12:36, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept1Fr (→Paroi cellulaire et enveloppe du vecteur tissulaire)
- 12:35, 20 October 2009 (diff | hist) File:MbMyco.png (uploaded a new version of "Image:MbMyco.png") (top)
- 12:32, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→The nuclear targeting)
- 12:32, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→The Encapsidation within the cell vector)
- 12:31, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→To summarize…)
- 12:31, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The system of cell targeting)
- 12:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector deliverance in the target organ)
- 12:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The encapsidation of the therapeutic plasmid)
- 12:30, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2 (→The cell vector: The lambda phage)
- 12:29, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliography
- 12:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3Fr (→Le ciblage nucléaire)
- 12:27, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3Fr (→L’encapsidation au sein du vecteur cellulaire)
- 12:25, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→Le système de ciblage cellulaire)
- 12:24, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→La délivrance du vecteur cellulaire dans l’organe cible)
- 12:23, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→L’encapsidation du plasmide thérapeutique)
- 12:22, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept2Fr (→Le vecteur cellulaire : Le bactériophage Lambda)
- 12:21, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies géniques (→La thérapie génique [1,3])
- 12:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies géniques (→La thérapie génique et ses problématiques [1])
- 12:20, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies géniques (→La thérapie génique et ses problématiques)
- 12:19, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Bibliographie
- 12:18, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies géniques (→Mode d’administration)
- 12:16, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies géniques (→La thérapie génique)
- 12:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies actuelles (→L’intérêt de la pharmacologie génétique) (top)
- 12:15, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Thérapies actuelles (→Les thérapies actuelles)
- 12:13, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→To summarize…)
- 12:12, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→To summarize…)
- 12:12, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→To summarize…)
- 12:10, 20 October 2009 (diff | hist) Team:SupBiotech-Paris/Concept3 (→The nuclear targeting)
(Latest | Earliest) View (newer 500 | older 500) (20 | 50 | 100 | 250 | 500)